Skip to content Loading
Heart Health & Diabetes

Treatment With Abacor, a Soy-Based Dietary Supplement, Further Reduces Plasma Concentrations of Total and Low-Density Lipoprotein Cholesterol in Statin-Treated Hypercholesterolaemic Patients

Study first page: Treatment with Abacor further reduces cholesterol in statin-treated hypercholesterolaemic patients

In 49 statin-treated patients with raised LDL cholesterol, adding a soy-based supplement (Abacor) for six weeks was tested for further reductions in total and LDL cholesterol.

Citation: Clausen P, Lindhardsen J, Hoie L, Stender S. Treatment with Abacor, a soy-based dietary supplement, further reduces plasma concentrations of total and low-density lipoprotein cholesterol in statin-treated hypercholesterolaemic patients. 2004.

Read the full paper (PDF)

Your cart
Your cart is empty
Have an account? Log in to check out faster.
Continue shopping Continue shopping
Cart total £0.00 GBP
Product image Product information Quantity Product total